Thalamic pain syndrome. 1985

J L Nuzzo, and C A Warfield

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001058 Apomorphine A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. Apokinon,Apomorphin-Teclapharm,Apomorphine Chloride,Apomorphine Hydrochloride,Apomorphine Hydrochloride Anhydrous,Apomorphine Hydrochloride, Anhydrous,Apomorphine Hydrochloride, Hemihydrate,Britaject,Apomorphin Teclapharm
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes
D013786 Thalamic Diseases Disorders of the centrally located thalamus, which integrates a wide range of cortical and subcortical information. Manifestations include sensory loss, MOVEMENT DISORDERS; ATAXIA, pain syndromes, visual disorders, a variety of neuropsychological conditions, and COMA. Relatively common etiologies include CEREBROVASCULAR DISORDERS; CRANIOCEREBRAL TRAUMA; BRAIN NEOPLASMS; BRAIN HYPOXIA; INTRACRANIAL HEMORRHAGES; and infectious processes. Dejerine-Roussy Syndrome,Thalamic Syndrome,Dejerine Roussy Syndrome,Disease, Thalamic,Diseases, Thalamic,Syndrome, Dejerine-Roussy,Syndrome, Thalamic,Syndromes, Thalamic,Thalamic Disease,Thalamic Syndromes

Related Publications

J L Nuzzo, and C A Warfield
January 2004, Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology,
J L Nuzzo, and C A Warfield
December 1989, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses,
J L Nuzzo, and C A Warfield
March 1972, Minnesota medicine,
J L Nuzzo, and C A Warfield
December 1990, The International journal of neuroscience,
J L Nuzzo, and C A Warfield
April 1956, Neurology,
J L Nuzzo, and C A Warfield
January 1993, Tropical and geographical medicine,
J L Nuzzo, and C A Warfield
November 1998, European journal of neurology,
J L Nuzzo, and C A Warfield
February 1994, Surgical neurology,
J L Nuzzo, and C A Warfield
March 2000, Palliative medicine,
J L Nuzzo, and C A Warfield
December 1996, Journal of neurology, neurosurgery, and psychiatry,
Copied contents to your clipboard!